RB1 and retinoblastoma: constructed a cancerous organoid model of RB using genetically engineered human embryonic stem cells with a biallelic mutation in the RB susceptibility gene RB1, which was highly consistent with primary RB tumorigenesis, transcriptomic characteristics, and genome-wide methylation (9).